Jean-Pierre Sommadossi

Insider Reports History

Location
Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jean-Pierre Sommadossi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Common Stock 5.87M $18M $3.06 31 Jan 2025 Held by JPM Partners LLC
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Common Stock 301K $921K $3.06 31 Jan 2025 Direct
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Restricted Stock Units 99.5K $305K $3.06 31 Jan 2025 Direct
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Stock Option (Right to Buy) 440K 31 Jan 2025 Direct
Kezar Life Sciences, Inc. Director Stock Option (Right to Buy) 26K 28 Jun 2021 Direct
ABG Acquisition Corp. I Director Class B ordinary shares 0 01 Mar 2023 Direct

Insider Reports Filed by Jean-Pierre Sommadossi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2025 6 -$271K 4 President, CEO, and Chairman, Director 04 Feb 2025, 18:00
AVIR Atea Pharmaceuticals, Inc. 17 Sep 2024 3 -$234K 4 President, CEO, and Chairman, Director 19 Sep 2024, 20:02
AVIR Atea Pharmaceuticals, Inc. 05 Jun 2024 1 -$4.02K 4 President, CEO, and Chairman, Director 07 Jun 2024, 18:34
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2024 4 -$219K 4 President, CEO, and Chairman, Director 02 Feb 2024, 21:30
ABGI ABG Acquisition Corp. I 01 Mar 2023 1 $0 4 Director 03 Mar 2023, 15:00
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2023 2 $0 4 President, CEO, and Chairman, Director 02 Feb 2023, 17:33
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2022 1 $0 4 President, CEO, and Chairman, Director 02 Feb 2022, 16:15
KZR Kezar Life Sciences, Inc. 28 Jun 2021 1 $0 4 Director 30 Jun 2021, 18:49